AiChemist Explainable AI for Molecules - AiChemist
- Coordinator
- Helmholtz Zentrum Muenchen Deutsches Forschungszentrum Fuer Gesundheit Und Umwelt GmbH, Germany
- Runs
- 1 September 2023 to 31 August 2027
- Status
- Running
- EU funding
- €3.0m
- Total cost
- —
- Partners
- 29 organisations in 11 countries
- Type
- Marie Skłodowska-Curie Action
- Grant agreement
- 101120466
What the project is doing
In the project's own words, from its summary on CORDIS.
Optimising biological activity and physico-chemical properties, while minimising their toxicity, are objectives when developing new compounds in chemical industries. Advanced machine learning (AI) methods are indispensable to this process. They are also increasingly used in environmental chemistry to identify compounds damaging to the environment and humans. Traditional machine learning (ML) methods provide reliable predictions though only for compounds similar to the training set, thus defining their applicability domain (AD).
Emerging representation learning approaches can efficiently approximate the physical interactions of molecules with an accuracy comparable to physics-based methods in only fractions of time. Models based on these representations should have much larger AD due to pre-training on large chemical sets of theoretical values. Here we will develop and benchmark representation learning approaches, addressing their accuracy and ADs, using public and in-house data for endpoints ranging from chemical reactions to toxicity.
While explainable AI (XAI) methods are actively developing in the ML community, there is a gap with their use in chemistry, i.e. there is a need to translate their results to the end users, chemists and regulatory bodies. Since the research program is tightly coupled with the target users - large companies, regulatory agencies and SMEs - it provides a clear path for technology transfer from academia to industry. AiChemist will provide structured training to its fellows through a combination of online courses and schools, strengthening European innovation capacity in the education of specialists in AI methods.
The fellows will receive comprehensive training in transferable skills. The complementary expertise and strong commitment of the partners make this ambitious innovative research program realistic via the proper allocation of individual tasks and resources, as described below.
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Helmholtz Zentrum Muenchen Deutsches Forschungszentrum Fuer Gesundheit Und Umwelt GmbH | Neuherberg | Germany | Coordinator |
| Chelonia SA | Lugano | Switzerland | Associatedpartner |
| Ecole Polytechnique Federale De Lausanne | Lausanne | Switzerland | Associatedpartner |
| Syngenta Crop Protection AG | Basel | Switzerland | Associatedpartner |
| Universita Della Svizzera Italiana | Lugano | Switzerland | Associatedpartner |
| Ascenion GmbH | Munich | Germany | Associatedpartner |
| Bayer Aktiengesellschaft | Leverkusen | Germany | Participant |
| Bigchem GmbH | Unterschleiheim | Germany | Associatedpartner |
| Molecular Networks GmbH Computerchemie | Nurnberg | Germany | Participant |
| Pfizer Pharma GmbH | Berlin | Germany | Participant |
| Technische Universitaet Muenchen | Muenchen | Germany | Participant |
| Kobenhavns Universitet | Kobenhavn | Denmark | Participant |
| Agencia Estatal Consejo Superior De Investigaciones Cientificas | Madrid | Spain | Participant |
| Fundacio Centre De Regulacio Genomica | Barcelona | Spain | Participant |
| Universitat De Barcelona | Barcelona | Spain | Associatedpartner |
| European Chemicals Agency | Helsinki | Finland | Associatedpartner |
| Cehtra | Cenon | France | Associatedpartner |
| Ecole Normale Superieure | Paris | France | Participant |
| Sanofi-Aventis Recherche & Developpement | Gentilly | France | Participant |
| Sorbonne Universite | Paris | France | Associatedpartner |
| Universite De Strasbourg | Strasbourg | France | Participant |
| Istituto Di Ricerche Farmacologiche Mario Negri | Milano | Italy | Participant |
| Korea Research Institute of Chemical Technology | Daejeon | South Korea | Associatedpartner |
| Technische Universiteit Eindhoven | Eindhoven | Netherlands | Participant |
| Universiteit Leiden | Leiden | Netherlands | Participant |
| Astrazeneca AB | Sodertaelje | Sweden | Participant |
| Altamira Llc | Columbus Oh | United States | Associatedpartner |
| National Institutes of Health | Bethesda | United States | Associatedpartner |
| U.S. Food & Drug Administration | Silver Spring | United States | Associatedpartner |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI